awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38357127-BD5F2A97-08E3-46AC-8DDF-BAB8FE3DF28C
Q38357127-BD5F2A97-08E3-46AC-8DDF-BAB8FE3DF28C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38357127-BD5F2A97-08E3-46AC-8DDF-BAB8FE3DF28C
Shifting paradigms in the treatment of chronic lymphocytic leukemia.
P2860
Q38357127-BD5F2A97-08E3-46AC-8DDF-BAB8FE3DF28C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38357127-BD5F2A97-08E3-46AC-8DDF-BAB8FE3DF28C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
03d3f53d77cc2c0bad3b123aaf9d43664630fb59
P2860
Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia.